VC News

Deal Announcements

Friday, February 12, 2016

  •  InAuth Lands Equity Venture Capital

    Friday, February 12, 2016 5:49:00 AM PDT | VentureDeal



    Venice, California  --  Security technology company InAuth has received $6.9 million in new equity venture capital funding, according to an SEC regulatory filing.

    InAuth has developed mobile-first authentication and fraud prevention technologies for e-commerce and banking applications.

    Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

    A total of 24 investors participated in the offering as amended.

    Company CEO Lisa Stanton was previously from Monitise, Citizens Financial Group and First NH Bank.

  •  DataCamp Collects Seed Venture Capital

    Friday, February 12, 2016 5:30:00 AM PDT | VentureDeal



    Cambridge, Massachusetts  --  Education technology company DataCamp has landed $1 million in seed stage venture capital funding.

    DataCamp says that it is the "first online learning platform that focuses on building the best learning experience for data science."

    Venture capital firm Accomplice (Christopher Lynch) made the investment.

    The company said it will use the capital to open a new office in Cambridge, grow its employee base and expand its library of data science learning resources.

    CEO Jonathan Cornelissen co-founded the company in July 2013.

Thursday, February 11, 2016

  •  Polyera Nets Venture Capital Debt

    Thursday, February 11, 2016 5:45:00 AM PDT | VentureDeal



    Skokie, Illinois  --  Advanced materials technology company Polyera has landed $13.66 million in new venture capital debt funding, according to an SEC regulatory filing.

    Polyera provides dielectric, interfacial and semiconductor materials for the printed and flexible electronics industry.

    Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

    A total of nine investors participated in the offering.

    Polyera is still seeking $4 million in additional debt financing, according to the filing.

  •  EndoShape Clears $7 Million Equity Venture Capital

    Thursday, February 11, 2016 5:19:00 AM PDT | VentureDeal



    Boulder, Colorado  --  Medical device technology company EndoShape has landed $7 million in new equity venture capital investment, according to an SEC regulatory filing.

    EndoShape develops medical devices "from innovative shape memory polymers."

    The company aims to provide medical devices that will provide minimally invasive and treatment options.

    Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

    A total of 16 investors participated in the offering.

    EndoShape is still seeking $2.8 million in additional equity investment, according to the filing.

Wednesday, February 10, 2016

  •  Genomind Grabs $2 Million New Investment

    Wednesday, February 10, 2016 5:49:00 AM PDT | VentureDeal



    King of Prussia, Pennsylvania  --  Personalized medicine company Genomind has secured $2 million in new venture equity investment, according to an SEC filing.

    Genomind has developed a noninvasive test for psychiatric conditions.

    Investors in the financing were not disclosed, nor was how the company intends to use proceeds.

    A total of 6 investors invested in the round as amended.

    The company is still seeking an additional $4 million in minimum investment increments of $250,000.

  •  8tracks Collects Equity Venture Capital

    Wednesday, February 10, 2016 5:30:00 AM PDT | VentureDeal



    San Francisco, California  --  Internet technology company 8tracks has landed $1.7 million in new equity venture capital funding, according to an SEC regulatory filing.

    8tracks says that it "offers a simple way for people to share and discover music through an online mix."

    Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

    A total of 36 investors participated in the offering.

    8tracks is still seeking $2.3 million in additional equity investment, according to the filing.

Tuesday, February 09, 2016

  •  Zentera Secures New Venture Investment

    Tuesday, February 09, 2016 5:49:00 AM PDT | VentureDeal



    San Jose, California  --  IT company Zentera has landed $2.5 million in new equity venture investment, according to an SEC regulatory filing.

    Zentera says that it "enables companies to extend production data center operations to public, private and managed hosted network domains."

    Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

    A total of three investors participated in the offering.

    Zentera is still seeking $250,000 in additional equity funding, according to the filing.

  •  Velano Vascular Clears Series A Financing

    Tuesday, February 09, 2016 5:30:00 AM PDT | VentureDeal



    San Francisco, California  --  Medical device technology company Velano Vascular has raised $3.5 million in its Series A institutional venture capital financing round.

    Velano is developing and commercializing an inpatient blood-draw technology for adult and pediatric applications.

    Investors in the round included First Round Capital, White Owl Capital, Kapor Capital and Safeguard Scientifics.

    The company said it would use the proceeds to continue developing its technology.

    CEO Eric Stone also co-founded the firm in April 2011.

Monday, February 08, 2016

  •  EpiBiome Raises Further Development Financing

    Monday, February 08, 2016 5:44:00 AM PDT | VentureDeal



    South San Francisco, California  --  Biotechnology company EpiBiome has secured $6 million in its first round of institutional venture capital funding.

    EpiBiome is developing "effective and sustainable FDA-approved therapies to combat infectious diseases in humans and in agriculture without the use of antibiotics."

    Investors in the round included Matrix Capital Management, Alexandria Venture Investments, SV Tech Ventures, ChinaRock Capital Management and Illumina Accelerator Program

    The company said it would use the funding to continue developing alternatives to small-molecule antibiotics.

    EpiBiome CEO Nick Conley has been with the firm since August 2013.

  •  Affinivax Nets Additional Strategic Investment

    Monday, February 08, 2016 5:14:00 AM PDT | VentureDeal



    Cambridge, Massachusetts  --  Biotechnology research company Affinivax has received $2.5 million in additional development investment.

    Affinivax is developing a "novel conjugation technology with the goal of designing vaccines that provide broad protection against challenging diseases afflicting children and adults in both the developing and developed worlds."

    The additional financing was provided by the Bill and Melinda Gates Foundation.

    Affinivax Said it intends to use the funding to advance its MAPS vaccine which targets Streptococcus pneumoniae.

    Pres. and CEO Steven Brugger has been with the firm since 2013.

Deal Announcement Archive »

Technology News

Friday, February 12, 2016

  •  DataRobot Snags $33 Million Series B Funding

    Friday, February 12, 2016 5:02:00 AM PDT | VentureDeal



    Boston, Massachusetts  --  Cloud software developer DataRobot has raised $33 million in its second round of institutional venture capital financing.

    DataRobot says that it is "creating a cloud platform to help teams of data scientists create the most accurate predictive models."

    New Enterprise Associates (Harry Weller) led the round which included Accomplice, Intel Capital, IA Ventures, Recruit and New York Life.

    The company said it would use the funding to aggressively expand its global operations across all functions.

    CEO Jeremy Achin has been with the company since April 2012.

Thursday, February 11, 2016

  •  Aplos Raises Series A Venture Capital

    Thursday, February 11, 2016 5:02:00 AM PDT | VentureDeal



    Fresno, California  --  Software technology company Aplos has secured $4 million in its first round of institutional venture capital funding.

    Aplos has developed accounting software that serves the nonprofit sector via its online system.

    San Joaquin Capital made the investment. San Joaquin specializes in providing startup capital for technology companies based in California's Central Valley.

    The company said it would use the funding to "accelerate and expand its product development efforts."

    Aplos was founded by CEO Tim Goetz in December 2008. Goetz is a licensed CPA.

Wednesday, February 10, 2016

  •  Venture Capital IPO Report - 2nd Half 2015

    Wednesday, February 10, 2016 7:15:00 AM PDT | VentureDeal

    During the second half of calendar year 2015, 29 venture capital-backed North American technology companies went public on US stock markets, raising a total of $5.85 billion in gross offering proceeds. This result represented a 35% sequential increase in gross proceeds when compared to the first half of 2015, which tallied $4.33 billion in gross proceeds.

    Life Science companies continue to dominate IPO market activity. 11 Biotechnology and 5 Pharmaceutical companies secured a combined total of $1.38 billion during the period, representing 24% of all IPO proceeds and accounting for over half of all technology companies going public. 2 Medical Device companies went public, raising $255 million.

    Three Software companies raised $643.2 million and three companies in the industries of Internet, Storage and Ecommerce collected $732 million in proceeds. Five companies in the remaining industries of Financial Services, Healthcare Services, Education, Networking and Semiconductors raised a combined $2.8 billion.

    The largest IPO of the half year period was that of Financial Services company First Data, which raised $2.56 billion in gross proceeds. With respect to pricing, 7 of the 29 IPOs priced above their expected range. 10 companies priced within the expected original or revised range and the remaining 12 companies priced below the original range sought. This represents a deterioration in pricing activity vs. the previous half-year period, with significantly fewer IPOs pricing above or within their expected range than in the previous period.

    The overall stock market exhibited a sharply downward trend during this period, with multiple Chinese mainland stock market crashes exerting a dampening effect and causing less visibility into market demand for new issues or outright reductions in offerings.

    The half-year period ended on a down note for all industries, with only one company floating its shares in the month of December. As of 1.31.2016, only 6 of the 29 IPO share prices were higher than their initial flotation price, reflecting a dramatically reduced demand in the wider stock market for technology shares.

    INTERNET


    There was only one Internet company IPO during the second half of 2014, continuing a recent trend of sparse offerings. Internet telephony company Ooma (NYSE: OOMA) floated its IPO, raising $65 million in gross proceeds. Headquartered in Palo Alto, California, the company provides a free Internet telephone calling service via its PureVoice HD service that is paired with an electronic phone device, the Telo, that it sells. Ooma had been backed by a syndicate of venture capital firms, including DFJ, Founders Fund, WI Harper and Worldview Technology Partners. Ooma’s original pricing range was $16 - $18 per share and the shares priced well below the range at $13 each. The share price has since performed poorly. As of 1.31.2016, OOMA closed at $6.79 per share, 48% lower than the IPO price.

    SOFTWARE


    There were three IPOs during the second half of the year for the Software industry, with gross proceeds totaling $643.2 million.

    In the largest Software IPO during the six-month period, Atlassian (NASDAQ: TEAM) raised $462 million in gross proceeds at a price of $21 per share, above the original per share range of $19 - $20. Atlassian provides enterprises with software that enhances team operations, from communications to software development and customer service. Company shares on the day of the flotation rose initially but have since fallen back to close down 1% from its original IPO price, as of 1.31.2016. Despite the drop, Atlassian’s share performance has been better than most other technology IPOs during the period.

    Watertown, Massachusetts-based Mimecast (NASDAQ: MIME) floated its offering and raised $7.5 million for its software, security and archiving services that provide a platform for email cloud services for enterprises. Mimecast priced its offering at $10 per share, within the expected range of $10 - $12, and the stock price has since fallen by 23%, to $7.67 as of 1.31.2016.

    BIOTECHNOLOGY


    There were 11 biotechnology IPOs during the second half of 2015, the same as in the previous six-month period, the most activity of any single industry. Gross proceeds totaled $1 billion, with two of the eleven IPOs pricing above their original range and two pricing within the expected range.

    San Carlos, California-based Natera (NASDAQ: NTRA) raised $180 million at $18 per share, at the high end of its estimated range of $17 - $18. Natera is a genetic testing company that sells bioinformatics technologies to companies to provide high throughput testing for reproductive indications from small quantities of DNA. The company was backed by a large syndicate of venture capital firms and late stage investors. Natera’s stock price since the IPO has dropped by 53% to close at $8.55 as of 1.31.2016.

    PHARMACEUTICAL

    Five venture capital-backed Pharmaceutical companies went public in the second half of 2015, raising $358 million in aggregate gross proceeds, versus four companies that went public in the second half of 2014. Pharmaceutical IPOs were not characterized by a single large IPO event. Newton, Massachusetts-based Chiasma (NASDAQ: CHMA) raised $102.4 million in gross proceeds at $16 per share, the only Pharmaceutical company to price above its expected range of $13 - $15 per share. The company is developing solutions for the non-invasive delivery of protein drugs. Its share price has since dropped by 36% to close at $10.30 as of 1.31.2016.

    MEDICAL DEVICES


    Two venture capital-backed Medical Device companies went public versus six IPOs in the previous 6 month period.

    Bedford, Massachusetts-based ConforMIS (NASDAQ: CFMS) raised $135 million in its IPO in July, 2015. ConforMIS provides minimally invasive medical implants for orthopedics and sports medicine treatments.. The company priced its shares at $15, withi its original expected range of $14 - $16 per share. The stock has since decreased 27%, closing at $11.00 as of 1.31.2016.

    OTHER INDUSTRIES


    There were five IPOs covering the remaining technology industries of Financial Services, Healthcare Services, Education, Networking and Semiconductors. Aggregate gross proceeds totaled $2.8 billion.

    Atlanta, Georgia-based First Data (NYSE: FDC) floated its IPO, raising $2.56 billion in gross proceeds, the largest technology IPO of the six-month period. The transaction processor’s IPO went out below its estimated range, pricing at $16 per share versus an original expected range of $18 - $20 per share. Since the IPO, the company’s stock has dropped by 16%, to close at $13.37 per share as of 1.31.2016.

    Education technology company Instructure (NYSE: INST) based in Salt Lake City, Utah raised $70.4 million in gross proceeds for its IPO that priced shares within its expected range of $16 - $18 per share. Instructure has developed technologies that it believes will set a “new, open standard for education technology.” The company was backed by US-based venture capital firms. Instructure’s stock price has held up well since the IPO given difficult overall stock market conditions, closing at $17.33 on 1.31.2016, representing an increase of 8% over the IPO flotation price.







    Not an offer or solicitation for sale of securities. This publication is not intended for use as a source of any advice such as investment, legal, medical, financial or accounting. The information contained herein may be subject to varying international, federal, state and/or local laws or regulations. VentureDeal utilizes data sources that it believes to be reliable, but cannot guarantee the accuracy or completeness of information presented. The purchaser or reader of this publication assumes responsibility for the use of these materials and information.

  •  Amperity Accepts $9 Million Series A

    Wednesday, February 10, 2016 5:02:00 AM PDT | VentureDeal



    Seattle, Washington  --  Digital media technology company Amperity has received $9 million in first round venture capital investment.

    Amperity is developing marketing technology that aims to "solve one of the biggest challenges faced by both marketing and IT organizations."

    Madrona Venture Group led the round, which included other individual investors.

    The company said it would use the funding to aggressively continue development of its data-first digital marketing application.

    Amperity CEO Kabir Shahani was previously from IMS Health and Appature.

Tuesday, February 09, 2016

  •  Canvas Receives Equity Venture Capital

    Tuesday, February 09, 2016 5:01:00 AM PDT | VentureDeal



    Reston, Virginia  --  Mobile technology company Canvas has secured $4 million in new equity venture capital funding, according to an SEC regulatory filing.

    Canvas has developed a mobile application technologies that enable field organizations to fill out forms much more quickly on a variety of mobile devices.

    Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

    A total of four investors participated in the offering.

    Canvas is still seeking $2 million in additional equity investment, according to the filing.

Monday, February 08, 2016

  •  FunnelWise Clears $7 Million Series A Funding

    Monday, February 08, 2016 5:02:00 AM PDT | VentureDeal



    Chicago, Illinois  --  Software developer FunnelWise has received $7 million in its first round of institutional venture capital financing.

    FunnelWise is developing what it calls "powerful revenue predictability software" that enables enterprises to gain visibility into marketing and sales performance.

    Investors in the financing were not disclosed.

    The company said it would use the funding to add more functionality to its solution and scale its sales and marketing efforts.

    CEO Mark Ostanik also founded the company and was previously an executive at the Textura Corporation.

Technology News Archive »

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


RSS Feeds

Add this page to your RSS aggregator page with a simple click of a button below.

Add to My Yahoo! Add to Netvibes
PCI - Level1